ClinicalTrials.gg
CompletedNCT01686646Updated Dec 8, 2014Results posted

Effects of Two Doses of a Common Cold Treatment on Alertness

A Phase 3 interventional study of paracetamol + caffeine and paracetamol in Common Cold, sponsored by GlaxoSmithKline. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-12-08.

Sponsored by GlaxoSmithKline · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 20 studies in Common Cold with a site in United Kingdom — none open to participants now, 1 under way, none of them phase 3. Common Cold · United Kingdom.

Enrollment
5th of 20
240 · median 89
Started
2011
with 2 others
Phase 3
4 of 20
none open now
Registered
9th of 20
by date
Lead sponsor
4 of 20
GlaxoSmithKline

Among the 20 studies in Common Cold with a site in United Kingdom, this one is the 5th largest by enrollment, is one of 3 that started in 2011, is one of 4 in phase 3, and was the 9th registered.

Common Cold

219 studies on the registry are indexed under Common Cold; 23 are open to participants now.

Browse Common Cold studies →

Open to participants now

None of the 20 studies in Common Cold with a site in United Kingdom is open now. The open studies under Common Cold, anywhere →

Who these studies take

Of the 14 Common Cold studies recruiting now, 4 (29%) set no upper age limit and 9 (64%) stop at 75 or younger; 4 take children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 20 studies in Common Cold with a site in United Kingdom as a file.
02

Study summary

This study will investigate any improvement in alertness and performance based on cognitive function and mood assessment in subjects suffering the common cold, when taking a novel paracetamol and caffeine combination verses paracetamol alone.

03

Conditions studied

  • Common Cold

Browse trials for

Keywords

  • alertness
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

  • Participants with symptoms of cold \< 96 hours, rating of at least '2' on malaise at least 4 other symptoms of cold.
  • No history of perennial rhinitis, no recent antibiotic, antihistamine or cold treatment, no caffeine in the previous 12 hours, no psychoactive medication in the 14 days prior to screening, no pregnancy, breastfeeding or participation in this trial, or another trial in the 30 days prior to screening.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
240 participants (actual)

Study arms

  • Active comparator
    highest dose Paracetamol + caffeine

    highest dose of Paracetamol and caffeine

    Drug: paracetamol + caffeine

  • Active comparator
    low-dose Paracetamol + caffeine

    lowest dose of Paracetamol and caffeine

    Drug: paracetamol + caffeine

  • Active comparator
    high dose paracetamol

    highest dose paracetamol

    Drug: paracetamol

  • Active comparator
    low dose paracetamol

    lowest dose paracetamol

    Drug: paracetamol

Interventions

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Number of Accurate Responses to Rapid Visual Information Processing (RVIP) Cognitive Test

    The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. The number of accurate responses to RVIP task was determined from the cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. This was identified in the output file by a value of '1' in 'TARGET=1' column. Also, the response time (in seconds) was recorded in the 'RT' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'. The test lasted approximately 9 minutes and number of accurate responses to stimulus was calculated.

    Time frame: Baseline to 60 minutes post treatment administration

Secondary outcomes

  1. Change From Baseline in Number of Accurate Responses to RVIP Cognitive Test

    The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. The number of accurate responses to RVIP task was determined from the cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. This was identified in the output file by a value of '1' in 'TARGET=1' column. Also, the response time (in seconds) was recorded in the 'RT' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'. The test lasted approximately 9 minutes and number of accurate responses to stimulus was calculated.

    Time frame: Baseline to 120 minutes post treatment administration

  2. Change From Baseline in Mean Time of Accurate Responses to RVIP Cognitive Task

    The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).

    Time frame: Baseline, 60 minutes and upto 120 minutes post treatment administration

  3. Change From Baseline in Number of Inaccurate and Missed Responses to RVIP Cognitive Task

    The no. of inaccurate responses to RVIP was determined from cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of screen. They responded to consecutive sequences of 3 odd or even numbers by pressing the corresponding response button. This was identified in the output file by a value of '1' in the 'TARGET=1' column. If a subject responded incorrectly to stimuli (pressed the response button at the wrong time), this was identified by a value of '-1' in the 'CORRECT=1' column. The no. of incorrect responses was calculated as the total no. of records where 'CORRECT=1' had a value of '-1'. If the subject missed a target (failed to press the response button within 600 msecs of being presented with a string of 3 consecutive even or odd numbers), this was considered a missed response and was calculated as the no. of records where there was a value of '1' in the 'TARGET=1' column and a value of '0' in the 'CORRECT=1' column.

    Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration

  4. Change From Baseline in Number of Accurate Responses to Sustained Attention Tasks (SAT) Cognitive Test

    Auditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained auditory attention task, participants were required to respond whenever they heard the number '8' in a continuous stream of numbers presented through headphones. This was identified in the output file by a value of '8' in the 'NUMBER' column. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appeared in a continuous stream of letters presented on a screen. This was identified in the output file by a value of 's' in the 'LETTER' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'.

    Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration

  5. Change From Baseline in Mean Time of Accurate Responses to SAT Cognitive Task

    The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).

    Time frame: Baseline, 30 minutes and up to 60 minutes post treatment administration

  6. Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive Test

    For sustained auditory attention task, participants were required to respond on hearing the no. '8' in a continuous stream of numbers through headphones. It was identified in output file by a value of '8' in 'NUMBER' column. For sustained visual attention task, participants responded to letter 's' every time it appeared in a continuous stream of letters presented on screen. This was identified in output file by a value of 's' in 'LETTER' column. If a subject responded incorrectly (pressed the response button at the wrong time), it was identified by a value of '-1' in 'CORRECT=1' column. The no. of incorrect responses was calculated as total no. of records where 'CORRECT=1' had a value of '-1'. The no. of missed responses (when subject failed to press the response button on hearing the number '8' or seeing the letter 's'), was calculated as the no. of records where there was a value of '8' in 'NUMBER' column or 's' in the 'LETTER' column and a value of '0' in the 'CORRECT=1' column.

    Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration

  7. Change From Baseline in Number of Valid Responses to Divided Attention Task (DAT) Cognitive Test

    Auditory and visual attention of participants was evaluated using a validated Divided Attention task. Participants were required to respond whenever they heard the number '8' in a continuous stream of numbers presented through headphones or saw a letter 's' on the screen . This was identified in the output file by a value of '8' in the 'NUMBER' column or by a value of 's' in the 'LETTER' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'.

    Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration

  8. Change From Baseline in Mean Time of Accurate Responses to DAT Cognitive Test

    The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).

    Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration

  9. Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive Test

    For the Divided Attention task, participants were required to respond on hearing the no. '8' in a continuous stream of numbers through headphones or seeing a letter 's' on screen. This was identified in the output file by a value of '8' in 'NUMBER' column or 's' in 'LETTER' column. If a subject responded incorrectly (pressed the response button at the wrong time), this was identified by a value of '-1' in 'CORRECT=1' column. The number of incorrect responses was calculated as the total no. of records where 'CORRECT=1' had a value of '-1'. If the subject missed a target (failed to press the response button on hearing the no. '8' or seeing the letter 's'), this was considered a missed response. The number of missed responses was calculated as the no. of records where there was a value of '8' in 'NUMBER' column or 's' in 'LETTER' column and a value of '0' in the 'CORRECT=1' column.

    Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration

07

Results

Posted Jul 14, 2014

Participant flow

Participants were recruited at the clinical site.

Participant flow — Overall Study
MilestoneParacetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)
Started45457575
Intent to treat population45457575
Safety population46457475
Completed45457575
Not completed0000

Outcome measures

PrimaryChange From Baseline in Number of Accurate Responses to Rapid Visual Information Processing (RVIP) Cognitive Test

The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. The number of accurate responses to RVIP task was determined from the cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. This was identified in the output file by a value of '1' in 'TARGET=1' column. Also, the response time (in seconds) was recorded in the 'RT' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'. The test lasted approximately 9 minutes and number of accurate responses to stimulus was calculated.

Time frame:
Baseline to 60 minutes post treatment administration
Reported as:
Least squares mean · Correct responses
Change From Baseline in Number of Accurate Responses to Rapid Visual Information Processing (RVIP) Cognitive Test
Correct responsesParacetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)
Change From Baseline in Number of Accurate Responses to Rapid Visual Information Processing (RVIP) Cognitive Test8.3 ± 1.124.8 ± 1.124.5 ± 0.892.7 ± 0.88
Statistical analysis
  • Paracetamol + Caffeine Combination (1000/130) vs Paracetamol (1000) · ANCOVA · p = 0.0248 (A hierarchical testing procedure was used such that p-values were only presented if the preceding treatment comparison was statistically significant (p\<0.05).) · Ls mean difference: 3.5 · 95% CI 0.4 to 6.5A positive difference favored the first named treatment.
  • Paracetamol + Caffeine Combination (500/65) vs Paracetamol (500) · ANCOVA · p = 0.1513 (A hierarchical testing procedure was used such that p-values were only presented if the preceding treatment comparison was statistically significant (p\<0.05).) · Ls mean difference: 1.7 · 95% CI -0.6 to 4.1A positive difference favoured the first named treatment.
  • Paracetamol + Caffeine Combination (1000/130) vs Paracetamol + Caffeine Combination (500/65) · ANCOVA · Ls mean difference: 3.9 · 95% CI 1.1 to 6.6A positive difference favoured the first named treatment.
SecondaryChange From Baseline in Number of Accurate Responses to RVIP Cognitive Test

The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. The number of accurate responses to RVIP task was determined from the cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. This was identified in the output file by a value of '1' in 'TARGET=1' column. Also, the response time (in seconds) was recorded in the 'RT' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'. The test lasted approximately 9 minutes and number of accurate responses to stimulus was calculated.

Time frame:
Baseline to 120 minutes post treatment administration
Reported as:
Least squares mean · Correct responses
Change From Baseline in Number of Accurate Responses to RVIP Cognitive Test
Correct responsesParacetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)
Change From Baseline in Number of Accurate Responses to RVIP Cognitive Test7.3 ± 1.164.4 ± 1.156.2 ± 0.913.5 ± 0.92
Statistical analysis
  • Paracetamol + Caffeine Combination (1000/130) vs Paracetamol (1000) · ANCOVA · p = 0.0696 (A hierarchical testing procedure was used such that p-values were only presented if the preceding treatment comparison was statistically significant (p\<0.05).) · Ls mean difference: 2.9 · 95% CI -0.2 to 6.1A positive difference favored the first named treatment.
  • Paracetamol + Caffeine Combination (500/65) vs Paracetamol (500) · ANCOVA · Ls mean difference: 2.7 · 95% CI 0.3 to 5.2A positive difference favored the first named treatment.
  • Paracetamol + Caffeine Combination (1000/130) vs Paracetamol + Caffeine Combination (500/65) · ANCOVA · Ls mean difference: 1.1 · 95% CI -1.7 to 3.9A positive difference favored the first named treatment.
SecondaryChange From Baseline in Mean Time of Accurate Responses to RVIP Cognitive Task

The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).

Time frame:
Baseline, 60 minutes and upto 120 minutes post treatment administration
Reported as:
Median · milliseconds (msec)
Change From Baseline in Mean Time of Accurate Responses to RVIP Cognitive Task
milliseconds (msec)Paracetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)
60 minutes-1.4 (-92 to 102)2.4 (-113 to 313)-0.9 (-134 to 119)-9.9 (-108 to 142)
120 minutes-10.3 (-62 to 125)-6.0 (-86 to 71)-12.5 (-91 to 109)-14.0 (-144 to 136)
SecondaryChange From Baseline in Number of Inaccurate and Missed Responses to RVIP Cognitive Task

The no. of inaccurate responses to RVIP was determined from cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of screen. They responded to consecutive sequences of 3 odd or even numbers by pressing the corresponding response button. This was identified in the output file by a value of '1' in the 'TARGET=1' column. If a subject responded incorrectly to stimuli (pressed the response button at the wrong time), this was identified by a value of '-1' in the 'CORRECT=1' column. The no. of incorrect responses was calculated as the total no. of records where 'CORRECT=1' had a value of '-1'. If the subject missed a target (failed to press the response button within 600 msecs of being presented with a string of 3 consecutive even or odd numbers), this was considered a missed response and was calculated as the no. of records where there was a value of '1' in the 'TARGET=1' column and a value of '0' in the 'CORRECT=1' column.

Time frame:
Baseline, 60 minutes and up to 120 minutes post treatment administration
Reported as:
Mean · inaccurate and missed responses
Change From Baseline in Number of Inaccurate and Missed Responses to RVIP Cognitive Task
inaccurate and missed responsesParacetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)
Incorrect responses at 60 minutes-5.7 ± 3.43-2.8 ± 1.381.4 ± 1.96-2.4 ± 1.82
Incorrect responses at 120 minutes-4.5 ± 4.12-1.7 ± 1.78-0.8 ± 1.97-3.3 ± 1.56
Missed responses at 60 minutes-8.1 ± 1.03-4.8 ± 1.18-4.8 ± 0.83-3.1 ± 0.89
Missed responses at 120 minutes-7.6 ± 1.14-4.8 ± 1.15-6.5 ± 0.80-3.5 ± 0.92
SecondaryChange From Baseline in Number of Accurate Responses to Sustained Attention Tasks (SAT) Cognitive Test

Auditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained auditory attention task, participants were required to respond whenever they heard the number '8' in a continuous stream of numbers presented through headphones. This was identified in the output file by a value of '8' in the 'NUMBER' column. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appeared in a continuous stream of letters presented on a screen. This was identified in the output file by a value of 's' in the 'LETTER' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'.

Time frame:
Baseline, 60 minutes and up to 120 minutes post treatment administration
Reported as:
Median · Correct responses
Change From Baseline in Number of Accurate Responses to Sustained Attention Tasks (SAT) Cognitive Test
Correct responsesParacetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)
Number of Accurate Responses to SAT at 60 mins1.0 (-4 to 16)0.5 (-16 to 43)2.0 (-9 to 33)0.0 (-28 to 15)
Number of Accurate Responses to SAT at 120 mins2.0 (-17 to 28)1.0 (-11 to 42)1.0 (-6 to 30)2.0 (-10 to 26)
SecondaryChange From Baseline in Mean Time of Accurate Responses to SAT Cognitive Task

The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).

Time frame:
Baseline, 30 minutes and up to 60 minutes post treatment administration
Reported as:
Least squares mean · msec
Change From Baseline in Mean Time of Accurate Responses to SAT Cognitive Task
msecParacetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)
60 minutes-16.7 ± 3.17-9.8 ± 3.17-10.8 ± 2.51-12.0 ± 2.47
120 minutes-21.2 ± 3.48-10.4 ± 3.48-18.0 ± 2.74-15.4 ± 2.72
SecondaryChange From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive Test

For sustained auditory attention task, participants were required to respond on hearing the no. '8' in a continuous stream of numbers through headphones. It was identified in output file by a value of '8' in 'NUMBER' column. For sustained visual attention task, participants responded to letter 's' every time it appeared in a continuous stream of letters presented on screen. This was identified in output file by a value of 's' in 'LETTER' column. If a subject responded incorrectly (pressed the response button at the wrong time), it was identified by a value of '-1' in 'CORRECT=1' column. The no. of incorrect responses was calculated as total no. of records where 'CORRECT=1' had a value of '-1'. The no. of missed responses (when subject failed to press the response button on hearing the number '8' or seeing the letter 's'), was calculated as the no. of records where there was a value of '8' in 'NUMBER' column or 's' in the 'LETTER' column and a value of '0' in the 'CORRECT=1' column.

Time frame:
Baseline, 60 minutes and up to 120 minutes post treatment administration
Reported as:
Mean · incorrect and missed responses
Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive Test
incorrect and missed responsesParacetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)
Incorrect responses at 60 minutes-4.6 ± 1.00-1.1 ± 0.87-4.2 ± 0.74-1.6 ± 0.71
Incorrect responses at 120 minutes-4.4 ± 1.04-2.3 ± 0.98-4.3 ± 0.88-2.8 ± 0.82
Missed responses at 60 minutes-2.7 ± 0.74-1.9 ± 1.25-2.3 ± 0.70-0.8 ± 0.66
Missed responses at 120 minutes-2.8 ± 1.11-2.0 ± 1.19-2.2 ± 0.64-2.4 ± 0.63
SecondaryChange From Baseline in Number of Valid Responses to Divided Attention Task (DAT) Cognitive Test

Auditory and visual attention of participants was evaluated using a validated Divided Attention task. Participants were required to respond whenever they heard the number '8' in a continuous stream of numbers presented through headphones or saw a letter 's' on the screen . This was identified in the output file by a value of '8' in the 'NUMBER' column or by a value of 's' in the 'LETTER' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'.

Time frame:
Baseline, 60 minutes and up to 120 minutes post treatment administration
Reported as:
Median · Correct responses
Change From Baseline in Number of Valid Responses to Divided Attention Task (DAT) Cognitive Test
Correct responsesParacetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)
60 minutes10.0 (-9 to 34)6.0 (-35 to 66)8.0 (-9 to 45)5.5 (-27 to 82)
120 minutes11.0 (-6 to 53)6.0 (-15 to 88)9.0 (-23 to 59)7.0 (-23 to 86)
SecondaryChange From Baseline in Mean Time of Accurate Responses to DAT Cognitive Test

The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).

Time frame:
Baseline, 60 minutes and up to 120 minutes post treatment administration
Reported as:
Least squares mean · msec
Change From Baseline in Mean Time of Accurate Responses to DAT Cognitive Test
msecParacetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)
60 minutes-3.0 ± 2.941.5 ± 2.94-4.4 ± 2.33-2.2 ± 2.28
120 minutes-11.0 ± 3.00-5.3 ± 3.00-8.0 ± 2.37-4.6 ± 2.34
SecondaryChange From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive Test

For the Divided Attention task, participants were required to respond on hearing the no. '8' in a continuous stream of numbers through headphones or seeing a letter 's' on screen. This was identified in the output file by a value of '8' in 'NUMBER' column or 's' in 'LETTER' column. If a subject responded incorrectly (pressed the response button at the wrong time), this was identified by a value of '-1' in 'CORRECT=1' column. The number of incorrect responses was calculated as the total no. of records where 'CORRECT=1' had a value of '-1'. If the subject missed a target (failed to press the response button on hearing the no. '8' or seeing the letter 's'), this was considered a missed response. The number of missed responses was calculated as the no. of records where there was a value of '8' in 'NUMBER' column or 's' in 'LETTER' column and a value of '0' in the 'CORRECT=1' column.

Time frame:
Baseline, 60 minutes and up to 120 minutes post treatment administration
Reported as:
Mean · incorrect and missed responses
Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive Test
incorrect and missed responsesParacetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)
Incorrect responses at 60 minutes-6.5 ± 1.02-4.2 ± 1.11-5.4 ± 0.87-3.3 ± 0.81
Incorrect responses at 120 minutes-7.1 ± 1.01-4.9 ± 1.10-5.6 ± 0.86-5.0 ± 0.98
Missed responses at 60 minutes-10.2 ± 1.27-7.6 ± 2.08-9.8 ± 1.19-6.2 ± 1.50
Missed responses at 120 minutes-12.2 ± 1.54-9.1 ± 2.27-10.2 ± 1.43-7.8 ± 1.58

Adverse events

Collected over Adverse events were collected from the start of the treatment, and until 5 days following administration of the last dose of investigational product.. Non-serious events are listed at a 1% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Paracetamol + Caffeine Combination (1000/130)—0/46 (0%)0/46 (0%)
Paracetamol (1000)—0/45 (0%)0/45 (0%)
Paracetamol + Caffeine Combination (500/65)—0/74 (0%)0/74 (0%)
Paracetamol (500)—0/75 (0%)0/75 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Paracetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)Total
Mean20.0 ± 1.5620.0 ± 1.7420.6 ± 4.1920.2 ± 2.8020.2 ± 2.98
Sex: Female, Male
Sex: Female, Male(Participants)Paracetamol + Caffeine Combination (1000/130)Paracetamol (1000)Paracetamol + Caffeine Combination (500/65)Paracetamol (500)Total
Female31284748154
Male1517272786
08

Study locations

1 site
  • Common Cold Centre
    Cardiff, Wales, United Kingdom
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2011, a primary completion of Nov 2012 and a completion of Nov 2012. It does not say whether these dates are actual or estimated.

Results were first posted in Jul 2014, 1 year 8 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 13, 2012
First posted
Sep 18, 2012
Start
Nov 2011
Primary completionActual
Nov 2012
CompletionActual
Nov 2012
Results first posted
Jul 14, 2014
Last update
Dec 8, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 8, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01686646
Lead sponsor
GlaxoSmithKline
Responsible party
Sponsor
First posted
Sep 18, 2012
Start date
Nov 2011
Primary completion
Nov 2012
Completion
Nov 2012
Results posted
Jul 14, 2014
Last update
Dec 8, 2014

Study contacts

GSK Clinical Trials
study director · GlaxoSmithKline

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Acetaminophen · Caffeine

Start the discussion